SCHEMBL7506552

SCHEMBL7506552

COc1ccc(-c2oc(Cc3ccccc3)nc2-c2ccc(S(N)(=O)=O)cc2)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 6/20 0.42
▸ CA9 Q16790 6/20 0.42
▸ CA1 P00915 5/20 0.42
▸ CA14 Q9ULX7 2/20 0.42
▸ CA7 P43166 1/20 0.42
▸ PTGS2 P35354 4/20 0.41
▸ PPARD Q03181 1/20 0.41
▸ PTGS1 P23219 3/20 0.41
▸ RXRA P19793 2/20 0.41
▸ RXRB P28702 2/20 0.41
▸ CA12 O43570 3/20 0.40
▸ KDR P35968 1/20 0.40
▸ NR4A2 P43354 4/20 0.40
▸ ENPP3 O14638 1/20 0.40
▸ IKBKB O14920 1/20 0.38
▸ CA13 Q8N1Q1 1/20 0.38
▸ NR4A1 P22736 1/20 0.38
▸ NR4A3 Q92570 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7505602 0.93 CA2 (0.42) CA2CA9CA1CA14CA7
SCHEMBL7508671 0.92 PTGS2 (0.45) PTGS2PPARDPTGS1RXRARXRB
SCHEMBL7505094 0.90 CA2 (0.47) CA2CA9CA1CA14CA7
SCHEMBL7496817 0.89 PTGS2 (0.43) CA2CA9CA1CA14CA7
SCHEMBL7505106 0.89 CA2 (0.48) CA2CA9CA1CA14PTGS2
SCHEMBL7507875 0.88 CA1 (0.43) CA2CA9CA1CA14CA7
SCHEMBL7509654 0.88 RXRA (0.46) CA2CA9CA1CA14CA7
SCHEMBL7510313 0.86 KDR (0.48) CA2CA9CA1CA14CA7
SCHEMBL7504923 0.86 KDR (0.48) CA2CA9CA1CA14CA7
SCHEMBL8555295 0.86 NR4A2 (0.36) CA2CA9CA1RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 — — EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 — — US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO disclosed
Send feedback